Skip to main content
BioThera Solutions

Building the manufacturing infrastructure for the extracellular vesicle economy.

Most exosome products cannot tell you what is in the vial. We can. BioThera produces extracellular vesicles with a process designed to scale, counts them by Nanoparticle Tracking Analysis, and characterizes every batch in line with MISEV2023, the consensus standard our founder helped write as a named contributor. One platform, one Certificate of Analysis, many applications.

Extracellular Vesicle (EV/Exosome)

Real-time structural model showing the bioactive molecules found in this nanoscale delivery system

Phospholipid bilayerSurface proteinsBiomolecular coronaIntraluminal cargoRNA molecules

What Does BioThera Solutions Do?

BioThera Solutions is a fully integrated extracellular vesicle company working across three layers: research and intellectual property, EV manufacturing with a process designed to scale, and characterization of every batch in line with MISEV2023. The same platform supplies every application built on it, and every batch leaves with its Certificate of Analysis.

01

EV Biomanufacturing

Scalable. Standardized. Reproducible.

Proprietary isolation and scale-up engineered for consistency: batch-level characterization, a shelf-stable lyophilized format, and standardized quality control across EV sources.

02

Characterization & Standards

MISEV2023, by a named contributor.

Every batch is counted by Nanoparticle Tracking Analysis and screened for contaminants, with characterization in line with MISEV2023. The number on the Certificate of Analysis is a measured number, not an estimate.

03

Applications

One platform, several fields of use.

The same workflow supplies cosmetic applications today, while our research team investigates dermatology, tissue repair, regenerative medicine and drug delivery, with therapeutic applications an important focus. One isolation and characterization process behind all of them.

One platform. Several fields of use.

BioThera produces extracellular vesicles, characterizes them in line with MISEV2023 and documents every batch. Formulation happens downstream of that. Cosmetic applications reach the market today through an exclusive licensing partner; everything else listed here is research, and therapeutic applications are an important focus.

See the applications

Cosmetics & skincare

Our technology is licensed exclusively to Vesera™, a skincare company and BioThera subsidiary, for cosmetic use, and we produce the EV material it uses.

Dermatology

Research with practicing dermatologists into how characterized extracellular vesicles behave in skin.

Tissue repair & regenerative medicine

Research into the vesicle cargo associated with tissue repair and regeneration.

Drug delivery

Research into extracellular vesicles as a natural carrier for therapeutic payloads.

Measured, not estimated.

Nanoparticle Tracking Analysis counts and sizes the vesicles in every batch. Transmission electron microscopy shows them directly, before and after lyophilization. The particle count on the Certificate of Analysis is a measured number.

Transmission electron microscopy image of non-lyophilized plant-derived extracellular vesicles: dark oval particles on a light background, with a 500 nm scale bar
Transmission electron microscopy (TEM) of BioThera's plant-derived extracellular vesicles before lyophilization. Positively stained vesicles. Scale bar: 500 nm.
Transmission electron microscopy image of plant-derived extracellular vesicles after lyophilization: dark oval particles on a light background, with a 500 nm scale bar
TEM of BioThera's plant-derived extracellular vesicles after lyophilization. Positively stained vesicles. Scale bar: 500 nm.
Chart of normalized particle concentration against particle size from 0 to 1000 nm, with a single peak near 200 nm
Representative size distribution of BioThera's plant-derived extracellular vesicles, measured by Nanoparticle Tracking Analysis (NTA).
Made in Canada
MISEV2023 Characterization
Leaping Bunny Certified
Patent Pending
Research with Practicing Dermatologists

Building with extracellular vesicles? Start a conversation.

We work with research, clinical and industry partners. Whether you are exploring co-development, licensing or a research collaboration, reach out.

Contact the team
BioThera Solutions

A fully integrated extracellular vesicle company, from research and intellectual property to manufacturing, with a process designed to scale. Extracellular vesicles (EVs/exosomes) are among biology's most promising delivery systems, and we are building the infrastructure the field has been missing.

Ottawa, Ontario, Canada
477-150 Louis-Pasteur Private Ottawa, Ontario K1N 9B4 Canada
Add BioThera Solutions as a preferred source on Google

© 2026 BioThera Solutions Inc. All rights reserved.

For informational purposes only. Nothing on this website is medical advice. BioThera develops and manufactures characterized extracellular vesicles (exosomes) and, for cosmetic applications, licenses its technology exclusively to Vesera™, a skincare company and BioThera subsidiary. Vesera™ products are cosmetics and are not intended to diagnose, treat, cure, or prevent any disease. BioThera does not sell products to consumers, and its work on therapeutic applications is research only.